These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17703634)

  • 1. Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
    Maillard MP; Burnier M
    Vasc Health Risk Manag; 2007; 3(3):265-78. PubMed ID: 17703634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan/hydrochlorothiazide: a new fixed dose combination.
    Maillard M; Burnier M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):375-86. PubMed ID: 15889965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
    Plosker GL; White WB
    Drugs; 2008; 68(13):1877-99. PubMed ID: 18729541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
    Shiga Y; Miura S; Mitsutake R; Norimatsu K; Nagata I; Arimura T; Shimizu T; Morii J; Kuwano T; Uehara Y; Inoue A; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):394-400. PubMed ID: 22427308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
    Vogt L; Navis G; Köster J; Manolis AJ; Reid JL; de Zeeuw D;
    J Hypertens; 2005 Nov; 23(11):2055-61. PubMed ID: 16208149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan: a review of its use in the management of hypertension.
    Battershill AJ; Scott LJ
    Drugs; 2006; 66(1):51-83. PubMed ID: 16398568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension.
    White WB; Punzi HA; Murwin D; Koval SE; Davidai G; Neutel JM
    J Clin Hypertens (Greenwich); 2006 Sep; 8(9):626-33. PubMed ID: 16957424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K; Isshiki M; Takahashi K;
    Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
    Neldam S; Schumacher H; Guthrie R
    Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.
    Gosse P
    Vasc Health Risk Manag; 2006; 2(3):195-201. PubMed ID: 17326326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S; Edwards C
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
    Kjeldsen SE; Schmieder RE; Unger T; Mancia G
    Curr Med Res Opin; 2010 Apr; 26(4):879-87. PubMed ID: 20144138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New standards in hypertension and cardiovascular risk management: focus on telmisartan.
    Galzerano D; Capogrosso C; Di Michele S; Galzerano A; Paparello P; Lama D; Gaudio C
    Vasc Health Risk Manag; 2010 Mar; 6():113-33. PubMed ID: 20448797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension.
    Schmieder RE
    Expert Opin Pharmacother; 2004 Nov; 5(11):2303-10. PubMed ID: 15500377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
    Arif AF; Kadam GG; Joshi C
    J Indian Med Assoc; 2009 Oct; 107(10):730-3. PubMed ID: 20469750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
    Fenton C; Keating GM; Scott LJ
    Drugs; 2003; 63(19):2013-26; discussion 2027-8. PubMed ID: 12962518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.